Xcopri FDA Approval History
FDA Approved: Yes (First approved November 21, 2019)
Brand name: Xcopri
Generic name: cenobamate
Dosage form: Tablets
Company: SK Life Science, Inc.
Treatment for: Seizures
Xcopri (cenobamate) is an antiepileptic drug for the treatment of partial-onset seizures in adult patients.
Development Timeline for Xcopri
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.